NCT03283969

Brief Summary

This proposal seeks to build upon studies, including ours, on the favorable effects of California strawberries on vascular health. Freeze dried strawberry powder (FDSP) contains a number of nutrients that may have beneficial effects on plasma lipids and vascular function, as well as on the composition of the gut microbiota; changes in the gut microbiota can in turn have secondary positive effects on the vascular system as well as on other physiological functions that are important determinants of health and disease. The proposed project will seek to determine the influence of short-term FDSP intake on the gut microbiota composition, and select microbial-derived metabolites from stool, serum and urine, and their relationship to microvascular function. Secondary outcomes will include the influence of the FDSP on circulating levels of nitrate and nitrite and trimethylamine oxide (TMAO) as markers of vascular health that are influenced by both dietary intake and the oral and gut microflora, with blood pressure as an additional vascular outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 13, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 15, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

June 6, 2022

Status Verified

June 1, 2022

Enrollment Period

4.4 years

First QC Date

September 13, 2017

Last Update Submit

June 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peripheral Arterial Tonometry (PAT)

    microvascular function testing

    10 weeks

Secondary Outcomes (7)

  • Gut Microbiome

    10 weeks

  • Untargeted Metabolomics

    10 weeks

  • Plasma Cholesterol

    10 weeks

  • Plasma LDL

    10 weeks

  • Plasma HDL

    10 weeks

  • +2 more secondary outcomes

Study Arms (2)

Control Powder

PLACEBO COMPARATOR

Isocaloric powder

Other: Freeze Dried Strawberry PowderOther: Isocaloric powder

Freeze Dried Strawberry Powder

EXPERIMENTAL

Contains freeze dried strawberries

Other: Freeze Dried Strawberry PowderOther: Isocaloric powder

Interventions

Study participants will be randomized to receive either the freeze dried strawberry powder or the control powder first. They will be instructed to consume 39g of the powder, mixed in water, every day for 4 weeks.

Control PowderFreeze Dried Strawberry Powder

Isocaloric powder

Control PowderFreeze Dried Strawberry Powder

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or postmenopausal female: 40-65 years
  • Women: lack of menses for at least two years.
  • Subject is willing and able to comply with the study protocols.
  • Subject is willing to participate in all study procedures
  • BMI 25.0 - 35 kg/m2

You may not qualify if:

  • BMI ≥ 35 kg/m2
  • Dislike or allergy for strawberries or strawberry products
  • Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
  • Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
  • Fruit consumption ≥ 2 cups/day
  • Regular consumption of strawberries (2-3 cups/week)
  • Vegetable consumption ≥ 3 cups/day for females
  • Fatty Fish ≥ 3 times/week
  • Coffee/tea ≥ 3 cups/day
  • Dark chocolate ≥ 3 oz/day
  • Self-reported restriction of physical activity due to a chronic health condition
  • Self-reported chronic/routine high intensity exercise
  • Self-reported diabetes
  • Blood pressure ≥ 140/90 mm Hg
  • Self-reported renal or liver disease
  • +13 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis; Department of Nutrition

Davis, California, 95616, United States

Location

MeSH Terms

Conditions

Communicable DiseasesCardiovascular DiseasesObesity

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Study Officials

  • Carl L Keen, PhD

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
The test powders where pre-packaged by the study sponsor and sent to the investigators coded.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized, double-blind, controlled crossover dietary intervention trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2017

First Posted

September 15, 2017

Study Start

August 1, 2017

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

June 6, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations